
BOOK NOW FOR your podcast
Beau Kilmer
McCauley Chair in Drug Policy Innovation
director of the RAND Drug Policy Research Center
senior policy researcher at the RAND Corporation
- Public Health
- Policy
- 📍Santa Monica, CA
Beau Kilmer (he/him) is the McCauley Chair in Drug Policy Innovation, director of the RAND Drug Policy Research Center, and a senior policy researcher at the RAND Corporation. His research lies at the intersection of public health and public safety, with special emphasis on crime control, substance use, illegal markets, and public policy.
Some of his current projects include analyzing the consequences of cannabis legalization (with a special focus on social equity); measuring the effect of 24/7 Sobriety programs on DUI, domestic violence, and mortality; facilitating San Francisco’s Street-Level Drug Dealing Task Force; and evaluating the evidence and arguments made about implementing heroin-assisted treatment and supervised consumption sites.
read more
LET'S TALK ABOUT
-
The pros/cons of different approaches to legalizing and taxing cannabis
-
How to estimate the size of illegal drug markets
-
Cannabis and social equity
--
Kilmer's publications have appeared in leading journals such as the New England Journal of Medicine and Proceedings of the National Academy of Sciences, and his commentaries have been published by CNN, Los Angeles Times, New York Times, San Francisco Chronicle, USA Today, Wall Street Journal, and other outlets. His co-authored book on cannabis legalization was published by Oxford University Press, and his coauthored book on the future of fentanyl and other synthetic opioids was published by RAND.
Kilmer received an NHTSA Public Service Award for his “leadership and innovation in the areas of alcohol and drug-impaired driving program and policy research,” and his coauthored work on 24/7 Sobriety received honorable mention for the Behavioural Exchange Award for Outstanding Research. He received his Ph.D. in public policy from Harvard University, M.P.P. from UC Berkeley, and B.A. in international relations from Michigan State University.
BOOK NOW FOR your podcast
Beau Kilmer
McCauley Chair in Drug Policy Innovation
director of the RAND Drug Policy Research Center
senior policy researcher at the RAND Corporation
- 📍Santa Monica, CA
- Public Health
- Policy
Beau Kilmer (he/him) is the McCauley Chair in Drug Policy Innovation, director of the RAND Drug Policy Research Center, and a senior policy researcher at the RAND Corporation. His research lies at the intersection of public health and public safety, with special emphasis on crime control, substance use, illegal markets, and public policy.
Some of his current projects include analyzing the consequences of cannabis legalization (with a special focus on social equity); measuring the effect of 24/7 Sobriety programs on DUI, domestic violence, and mortality; facilitating San Francisco’s Street-Level Drug Dealing Task Force; and evaluating the evidence and arguments made about implementing heroin-assisted treatment and supervised consumption sites.
read more
LET'S TALK ABOUT
-
The pros/cons of different approaches to legalizing and taxing cannabis
-
How to estimate the size of illegal drug markets
-
Cannabis and social equity
--
Kilmer's publications have appeared in leading journals such as the New England Journal of Medicine and Proceedings of the National Academy of Sciences, and his commentaries have been published by CNN, Los Angeles Times, New York Times, San Francisco Chronicle, USA Today, Wall Street Journal, and other outlets. His co-authored book on cannabis legalization was published by Oxford University Press, and his coauthored book on the future of fentanyl and other synthetic opioids was published by RAND.
Kilmer received an NHTSA Public Service Award for his “leadership and innovation in the areas of alcohol and drug-impaired driving program and policy research,” and his coauthored work on 24/7 Sobriety received honorable mention for the Behavioural Exchange Award for Outstanding Research. He received his Ph.D. in public policy from Harvard University, M.P.P. from UC Berkeley, and B.A. in international relations from Michigan State University.
As seen on
Timeline
Jan 2021 - Present
RAND Corporation
McCauley Chair in Drug Policy Innovation
Aug 2019 - Present
Director of the RAND Drug Policy Research Center
May 2011 - Present
Senior Policy Researcher
Sep 2008 - Aug 2019
Co-Director of the RAND Drug Policy Research Center
Aug 2017 - Jan 2018 / Jun 2018 - Feb 2019
Interim Director of RAND San Francisco Bay Area
May 2009 - May 2011
Full Policy Researcher
Jul 2007 - May 2009
Associate Policy Researcher
May 1997 - Oct 2003 / Jun 2006 - Jul 2007
Adjunct Staff
Jan 2004 - Jun 2006
National Bureau of Economic Research
Research Assistant
May 2003 - Sep 2003
Harvard University
Research Assistant
Oct 2001 - Aug 2002
Superior Court of California,
San Francisco
Administrative Analyst
Ask me
What is happening with cannabis legalization in the US and around the world? |
How can we reduce the number of people dying from fentanyl? |
What is harm reduction and what does the evidence say about it? |
What does the future of technology and drug policy look like? |
What does the research say about revoking someone’s “license to drink”? |